Fulgent Genetics Inc (FLGT) — Cash Flow Reinvestment Rate

Latest as of March 2026: 10.84x

Fulgent Genetics Inc (FLGT) has a Cash Flow Reinvestment Rate of 10.84x as of March 2026, reinvesting $76.90 Million (capex $5.20 Million plus investments $71.70 Million) from operating cash flow of $7.10 Million. Explore how much does Fulgent Genetics Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

10.84x
(Capex + Investments) / Operating CF

Total Reinvested

$76.90 Million
Capex + Investments

Operating Cash Flow

$7.10 Million
USD

Capital Expenditures

$5.20 Million
USD

Fulgent Genetics Inc Cash Flow Reinvestment Rate (2016–2024)

Historical reinvestment intensity for Fulgent Genetics Inc across 8 annual periods. Also explore how large is Fulgent Genetics Inc's balance sheet for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Fulgent Genetics Inc (2016–2024)

Year-by-year capital reinvestment analysis for Fulgent Genetics Inc. For live market cap and broader valuation context, see FLGT company net worth.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2024 4.69x $98.67 Million $21.06 Million $40.31 Million ▲ +107.0%
2023 2.26x $61.10 Million $27.00 Million $22.21 Million ▲ +104.8%
2022 1.10x $280.09 Million $253.52 Million $18.77 Million ▲ +22.7%
2021 0.90x $484.74 Million $538.58 Million $23.84 Million ▼ -61.2%
2020 2.32x $326.45 Million $140.63 Million $36.51 Million ▼ -55.9%
2019 5.26x $29.05 Million $5.52 Million $1.18 Million ▼ -19.1%
2017 6.51x $8.66 Million $1.33 Million $5.36 Million ▼ -38.5%
2016 10.58x $46.58 Million $4.41 Million $3.79 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow